Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Medicine Insights. Case Reports|February 24, 2023
Gemcitabine-Induced Myositis in a Luminal B Breast Cancer patient: A Case ReportAhmed Badran, Saad Salman Ali, Tarek Ziad Arabi, et al.
The Oncologist|January 17, 2023
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II TrialShouki Bazarbashi, Ahmed Alzahrani, Ali Aljubran, et al.
Oncology Letters|July 25, 2024
Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancerBader Alshamsan, Mahmoud A Elshenawy, Mohamed Aseafan, et al.
Cancer Management and Research|January 10, 2022
Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast CancerBader Alshamsan, Aisha Alshibany, Mahmoud A Elshenawy, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 7, 2022
Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine TumorsAli Aljubran, Ahmed Badran, Mohamed Alrowaily, et al.
Cureus|December 7, 2022
Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution ExperienceHamed Alhusaini, Mahmoud A Elshenawy, Ahmed Badran, et al.
Annals of Surgical Oncology|August 30, 2022
Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized StudyShouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, et al.
Cureus|May 16, 2024
The Effectiveness of Denosumab in Middle Eastern Patients With Giant Cell Tumor of the Bone: A Single-Center, Retrospective StudyMahmoud Elshenawy, Tarek Z Arabi, Heba A Ateya, et al.
Oncology|January 10, 2020
Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?Kausar Suleman, Osama Almalik, Emaan Haque, et al.
Annals of Medicine and Surgery (2012)|February 9, 2024
Suspected NUT carcinoma progressing on pembrolizumab, carboplatin, and paclitaxel as first-line treatment: a case reportAhmed Badran, Saad Salman Ali, Tarek Ziad Arabi, et al.
Pageof 3